• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[遗传性出血性毛细血管扩张症(伦杜-奥斯勒-韦伯病)的肝脏受累。1例报告并文献复习]

[Liver involvement in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease). Report of one case and review of the literature].

作者信息

Proux A, Tapiero S, Girszyn N, Levesque H, Marie I

机构信息

Service de médecine interne, CHU de Rouen-Boisguillaume, 1, rue de Germont, 76031 Rouen cedex, France.

出版信息

Rev Med Interne. 2007 Nov;28(11):775-9. doi: 10.1016/j.revmed.2007.06.005. Epub 2007 Jun 28.

DOI:10.1016/j.revmed.2007.06.005
PMID:17624637
Abstract

INTRODUCTION

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplasia; mutations in at least three genes (ENG, ACVRL1 et MADH4), which are components of transforming growth factor (TGF)-beta, may lead to the clinical picture of HHT. HHT is a multisystemic angiodysplasia, resulting in multiple vascular malformations, involving notably the liver.

EXEGESIS

We report the case of a patient with anicteric cholestasis, revealing HHT. Abdominal CT-scan revealed hepatic artery dilation and multiple arteriovenous fistula. At 2-year follow-up, the patient exhibited liver involvement-associated high output cardiac insufficiency.

CONCLUSION

Liver involvement is frequent in HHT, occurring in 8-31% of patients; it may lead to life-threatening complications, such as high output cardiac failure, portal hypertension or severe cholangitis. Abdominal Doppler ultrasonography is a non-invasive accurate method, suitable for first-line imaging of the liver in patients with HHT; it should be done in all patients, in order to detect HHT-related hepatic vascular malformations.

摘要

引言

遗传性出血性毛细血管扩张症(HHT)是一种常染色体显性血管发育异常疾病;至少三个基因(ENG、ACVRL1和MADH4)发生突变,这些基因是转化生长因子(TGF)-β的组成部分,可能导致HHT的临床表现。HHT是一种多系统血管发育异常疾病,会导致多个血管畸形,尤其是累及肝脏。

注释

我们报告了一例以无黄疸型胆汁淤积为表现而确诊为HHT的患者。腹部CT扫描显示肝动脉扩张和多处动静脉瘘。在2年的随访中,该患者出现了与肝脏受累相关的高输出量心力衰竭。

结论

肝脏受累在HHT中很常见,发生率为8%-31%的患者;它可能导致危及生命的并发症,如高输出量心力衰竭、门静脉高压或严重胆管炎。腹部多普勒超声检查是一种非侵入性的准确方法,适用于HHT患者肝脏的一线成像检查;应对所有患者进行此项检查,以便检测与HHT相关的肝脏血管畸形。

相似文献

1
[Liver involvement in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease). Report of one case and review of the literature].[遗传性出血性毛细血管扩张症(伦杜-奥斯勒-韦伯病)的肝脏受累。1例报告并文献复习]
Rev Med Interne. 2007 Nov;28(11):775-9. doi: 10.1016/j.revmed.2007.06.005. Epub 2007 Jun 28.
2
Liver involvement in hereditary haemorrhagic telangiectasia or Rendu-Osler-Weber disease.遗传性出血性毛细血管扩张症(即伦迪-奥斯勒-韦伯病)中的肝脏受累情况。
Dig Liver Dis. 2005 Sep;37(9):635-45. doi: 10.1016/j.dld.2005.04.010.
3
Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.贝伐单抗可逆转遗传性出血性毛细血管扩张症患者对肝移植的需求。
Liver Transpl. 2008 Feb;14(2):210-3. doi: 10.1002/lt.21417.
4
[Hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) and its manifestation in the liver].
Z Gastroenterol. 2001 Jul;39(7):533-42. doi: 10.1055/s-2001-15969.
5
Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.遗传性出血性毛细血管扩张症的肝移植:欧洲肝脏移植登记处报告
Ann Surg. 2006 Dec;244(6):854-62; discussion 862-4. doi: 10.1097/01.sla.0000247258.35406.a4.
6
Identifying the presence of clinically significant hepatic involvement in hereditary haemorrhagic telangiectasia using a simple clinical scoring index.使用简单的临床评分指数识别遗传性出血性毛细血管扩张症中具有临床意义的肝受累情况。
J Hepatol. 2014 Jul;61(1):124-31. doi: 10.1016/j.jhep.2014.02.028. Epub 2014 Mar 6.
7
Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia.在德国遗传性出血性毛细血管扩张症患者中检测ACVRL1基因突变与肝脏受累之间的显著关联。
Clin Genet. 2008 Aug;74(2):171-7. doi: 10.1111/j.1399-0004.2008.01029.x. Epub 2008 May 21.
8
[Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].[贝伐单抗:遗传性出血性毛细血管扩张症治疗的新突破]
Rev Med Interne. 2015 Sep;36(9):623-5. doi: 10.1016/j.revmed.2014.11.004. Epub 2015 Jan 13.
9
Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).遗传性出血性毛细血管扩张症(伦杜-奥斯勒病)的肺血管表现
Respiration. 2007;74(4):361-78. doi: 10.1159/000103205.
10
Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.遗传性出血性毛细血管扩张症中的肝脏表现与ALK1相关:鉴定出五个新的ALK1突变和一个新的ENG突变。
Hum Mutat. 2005 Mar;25(3):320. doi: 10.1002/humu.9311.